An animal comparison cannot establish clinical superiority of human rescue products.
In a pilocarpine-induced mouse seizure model, intranasal diazepam showed stronger early seizure control than the tested midazolam and lorazepam conditions. The investigators examined brain-to-plasma distribution and other laboratory properties to explore the difference.
Species, formulation, exposure and induced seizure type restrict translation. Similar receptor-binding measures do not ensure identical distribution, and a distribution association does not isolate the complete causal mechanism.
Keep the ten-minute animal endpoint separate from human seizure termination, recurrence and safety. The paper cannot establish that changing a person’s prescribed rescue medication would improve outcomes. Forensic reconstruction requires the actual product, delivery, timing, clinical response and the patient’s seizure context.
Source: PMC12963071, supplied full-text paper. Findings are paraphrased; forensic implications are an interpretation.
Related: Neonatal Seizure Control Was Assessed Clinically Without EEG in a Midazolam Comparison.